Pediatric heart failure

Minerva Cardioangiologica

Volumn 56, Issue 3, 2008, Pages 311-319

  Picchio, F M ^a,b   Formigari, R ^a   Balducci, A ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Istituto di Cardiologia   (Italy)

Author keywords

Child; Heart failure, diagnosis; Heart failure, therapy

Indexed keywords

ADRENALIN; AMRINONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE; ENALAPRIL; FUROSEMIDE; GLYCERYL TRINITRATE; INOTROPIC AGENT; LEVOSIMENDAN; LOOP DIURETIC AGENT; METOPROLOL; MILRINONE; NESIRITIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; PROPRANOLOL; SPIRONOLACTONE;

ACUTE HEART FAILURE; CARDIAC RESYNCHRONIZATION THERAPY; CHILDHOOD DISEASE; CLINICAL FEATURE; CONGENITAL HEART DISEASE; CONTINUOUS INFUSION; DEFIBRILLATOR; HEART ARRHYTHMIA; HEART ASSIST DEVICE; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART TRANSPLANTATION; HUMAN; INFANT DISEASE; REVIEW; SURVIVAL; TREATMENT INDICATION; TREATMENT OUTCOME;

CHILD; HEART FAILURE; HUMANS;

EID: 46749123056     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Katz AM. Heart failure: pathophysiology, molecular biology and clinical management. Philadelphia: Lippincott, Williams & Wilkins; 2000.
2. Margossian R. Contemporary management of pediatric heart failure. Expert Rev Cardiovasc. Ther 2008;6:187-97.
3. Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003;348:1647-55.
4. Nugent AW, Daubeney PEF, Chondros P, Carlin JB, Cheung M, Wilkinson LC et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003;348:1639-46.
5. Odland HH, Thaulow E. Heart failure in children. Expert Rev Cardiovasc Ther 2006;4:33-40.
6. Bouzas B, Kilner PJ, Gatzoulis MA. Pulmonary regurgitation: not a benign lesion. Eur Heart J 2005;26:433-9.
7. Bolger AP, Sharma R, Li WM, Leenarts M, Kalra PR, Kemp M et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002;106:92-9.
8. Davos CH, Davlouros PA, Wensel R, Francis D, Davies LC, Kilner PJ et al. Global impairment of cardiac autonomic nervous activity late after repair of tetralogy of Fallot. Circulation 2002;106(12 Suppl. 1):I69-I75.
9. Johnstone DE, Apdulla A, Arnold JM, Bernstein V, Bourassa M, Brophy J et al. Diagnosis and management of heart failure. Canadian Cardiovascular Society. Can J Cardiol 1994;10:613-31.
10. Connolly D, Rutkowski M, Auslender M, Artman M. The New York University Pediatric Heart Failure Index: a new method of quantifying chronic heart failure severity in children. J Pediatr 2001;138:644-8.
11. Rosenthal D, Chrisant MRK, Edens E, Mahony L, Canter C, Colan S et al. International society for heart and lung transplantation: practice guidelines for management of heart failure in children. J Heart Lung Transplant 2004;23:1313-3.
12. Ross RD, Bollinger RO, Pinsky WW. Grading the severity of heart failure in infants. Pediatr Cardiol 1992;13:72-5.
13. th Edition. Philadelphia, USA, Saunders; 2008.
14. Edelman RR. Contrast-enhanced MR imaging of the heart: overview of the literature. Radiology 2004;232:653-68.
15. Fredriksen PM, Veldtman G, Hechter S, Therrien J, Chen A, Warsi MA et al. Aerobic capacity in adults with various congenital heart diseases. Am J Cardiol 2001;87:310-4.
16. Arena R, Myers J, Aslam SS, Varughese EB, Peberdy MA. Peak Vo2 and VE/Vco2 slope in patients with heart failure : a prognostic comparison. Am Heart J 2004;147:354-60.
17. Giardini A, Specchia S, Berton E, Sangiorgi D, Coutsoumbas G, Gargiulo G et al. Strong and independent prognostic value of peak circulatory power in adults with congenital heart disease. Am Heart J 2007 154:441-7.
18. Nir A, Nasser N. Clinical value of NT-ProBNP and BNP in pediatric cardiology. J. Card. Fail.2005;11(5 Suppl):S76-S80.
19. Berman W Jr, Yabek SM, Dillon T, Niland C, Corlew S, Christensen D. Effects of digoxin in infants with congested circulatory state due to a ventricular septal defect. N Engl J Medic 1983;308:363-6.
20. Ferguson DW, Berg WJ, Sanders JS, Roach PJ, Kempf JS, Kienzle MG. Sympathoinhibitory responses to digitalis glycosides in heart failure patients: direct evidence from sympathetic neural recordings. Circulation 1989;80:65-77.
21. Covit AB, Schaer GI, Sealey JE, Laragh JH, Cody RJ. Suppression of the rennin-angiotensin system by intravenous digoxin in chronic congestive heart failure. Am J Med 1983;75:445-7.
22. Hobbins SM, Fowler RS, Rowe RD, Korey AG. Spironolactone therapy in infants with congestive heart failure secondary to congenital heart disease. Arch Dis Child 1981;56:934-8.
23. Grenier MA, Fioravanti J, Truesdell SC, Mendelson AM, Vermilion RP, Lipshultz SE. Angiotensin-Converting enzyme inhibitor therapy for ventricular dysfunction in infants, children and adolescents: a review. Prog Pediatr Cardiol 2000;12:91-111.
24. Leversha AM, Wilson NJ, Clarkson PM, Calder AL, Ramage MC, Neutze JM. Efficacy and dosage of enalapril in congenital and acquired heart disease. Arch Dis ChUd 1994;70:35-9.
25. Lewis AB, Chabot M. The effect of treatment with angiotensin-converting enzyme inhibitors on survival of pediatric patients with dilated cardiomyopathy. Pediatr Cardiol 1993;14:9-12.
26. Webster MW, Neutze JM, Calder AL. Acute hemodynamic effects of converting enzyme inhibition in children with intracardiac shunts. Pediatr Cardiol 1992;13:129-35.
27. Shaddy RE, Curtin EL, Sower B, Tani LY, Burr J, LaSalle B et al. The Pediatric Randomized Carvedilol Trial in Children with Heart Failure: rationale and design. Am Heart J 2002;144:383-9.
28. Shaddy RE, Boucek MM, Hsu DT, Boucek RJ, Canter CE, Mahony L et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA 2007;298:1171.-9.
29. Giardini A, Lovato L, Donti A, Formigari R, Gargiulo G, Picchio FM et al. A pilot study on the effects of Carvedilol on right ventricular remodelling and exercise tolerance in patients with systemic right ventricle. Int J Cardiol 2006;10 [Epub ahead of print].
30. Bruns LA, Chrisant MK, Lamour JM, Shaddy RE, Pahl E, Blume ED et al. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. J Pediatr 2001;138:505-11.
31. Rusconi P, Gómez-Marín O, Rossique-González M, Redha E, Marín JR, Lon-Young M et al. Carvedilol in children with cardiomyopathy: 3-year experience at a single institution. J. Heart Lung Transplant 2004;23;832-8.
32. Williams RV, Tani LY, Shaddy RE. Intermediate effects of treatment with metoprolol or carvedilol in children with left ventricular systolic dysfunction. J Heart Lung Transplant 2002;21:906-9.
33. Ross RD, Daniels SR, Schwartz DC, Harmon DW, Shukla R, Kaplan S. Plasma norepinephrine levels in infants and children with congestive heart failure. Am J Cardiol 1987;59:911-4.
34. Latifi S, Lidsky K, Blumer JL. Pharmacology of inotropic agents in infants and children. Prog Pediatr Cardiol 2000;12:57-79.
35. Laitinen P, Happonen JM, Sairanen H, Peltola K, Rautiainen P, Korpela R et al. Amrinone versus dopamine-nitroglycerin after reconstructive surgery for complete atrioventricular septal defect. J Cardiothorac Vasc Anesth 1997;11:870-4.
36. Laitinen P, Ahonen J, Olkkola KT, Peltola K, Rautiainen P, Rasanen J. Pharmacokinetics of amrinone in neonates and infants. J Cardiothorac Vasc Anesth 2000;14:378-82.
37. Hoffman TM, Wernovsky G, Atz AM, Bailey JM, Akbary A, Kocsis JF et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMA-CORP) study. Prophylactic Intravenous Use of Milrinone After Cardiac Operation in Pediatrics. Am Heart J 2002;143:15-21.
38. Auslender M. New drugs in the treatment of heart failure. Progress in Pediatr Cardiol 2000;12:119-24.
39. Bailey JM, Hoffman TM, Wessel DL, Nelson DP, Atz AM, Chang AC et al. A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery. J. Pharmacokinet. Pharmacodyn 2004;31:43-59.
40. Turanlahti M, Boldt T, Palkama T, Antila S, Lehtonen L, Pesonen E. Pharmacokinetics of levosimendan in pediatric patients evaluated for cardiac surgery. Pediatr. Crit. Care Med 2004;5:457-62.
41. Mahle WT, Cuadrado AR, Kirshom PM, Kanter KR, Simsic JM. Nesiritide in infants and children with congestive heart failure. Pediatr Crit Care Med 2005;6:543-6.
42. Young JB, Abraham WT, Smith AL Leon AR, Lieberman R, Wilkoff B et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 2003;289:2685-94.
43. Alexander ME, Berul CI, Fortescue EB, Blume E, Brown D, Triedman JK et al. Who is eligible for cardiac resyncrhonizationtherapy in pediatric cardiology? Heart Rhythm 2004; 1(1S): S122.
44. Janousek J, Vojtovic P, Hucin B, Tláskal T, Gebauer RA, Gebauer R et al. Resynchronization pacing is a useful adjunct to the management of acute heart failure after surgery for congenital heart defects. Am J Cardiol 2001;88:145-52.
45. Zimmerman FJ, Starr JP, Koenig PR, Smith P, Hijazi ZM, Bacha EA. Acute hemodynamic benefit of multisite ventricular pacing after congenital heart surgery. Ann Thorac Surg 2003;75:1775-80.
46. Bacha EA, Zimmerman FJ, Mor-Avi V, Weinert L, Starr JP, Sugeng L et al. Ventricular resynchronization by multisite pacing improves myocardial performance in the postoperative single-ventricle patient. Ann Thorac Surg 2004;78:1678-83.
47. Stephenson EA, Cecchin F, Alexander ME, Triedman JK, Walsh EP, Berul CI. Relation of right ventricular pacing in tetralogy of Fallot to electrical resynchronization. Am J Cardiol 2004;93:1449-52, A12.
48. Janousek J, Tomek V, Chaloupecky VA, Reich O, Gebauer RA, Kautzner J et al. Cardiac resynchronization therapy: a novel adjunct to the treatment and prevention of systemic right ventricular failure. J Am Coll Cardiol 2004;44:1927-31.
49. Dubin AM, Feinstein JA, Reddy VM, Hanley FL, Van Hare GF, Rosenthal DN. Electrical resynchronization: a novel therapy for the failing right ventricle. Circulation 2003;107:2287-9.
50. Dubin AM, Janousek J, Rhee E, Strieper MJ, Cecchin F, Law IH et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol 2005;46:2277-83.
51. Dubin AM, Berul CI. Electrophysiological interventions for treatment of congestive heart failure in pediatrics and congenital heart disease. Expert Rev Cardiovasc Ther 2007;5:111-8. Review
52. Dubin AM, Berul CI, Bevilacqua LM, Collins KK, Etheridge SP, Fenrich AL et al. The use of implantable cardioverter-defibrillators in pediatric patients awaiting heart transplantation. J Card Fail 2003;9:375-9.
53. Potapov EV, Stiller B, Hetzer R. Ventricular assist devices in children: current achievements and future perspectives. Pediatr Transplantation 2007;11:241-55.
54. Davies M, Russo K, Hong M, O'Byrne D, Cork A, Moskowitz A et al. The use of mechanical circulatory support as a bridge to transplantation in pediatric patients: An analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg 2008;135:421-7.
55. Cooper DS, Jacobs JP, Moore L, Stock A, Gaynor JW, Chancy T et al. Cardiac extracorporeal life support: state of the art in 2007. Cardiol Young 2007;17(Suppl 2):104-15.
56. Baldwin T, Borovetz H, Duncan B, Gartner MJ, Jarvik RK, Weiss WJ et al. The National Heart, Lung and Blood Institute Pediatric Circulatory Support Program. Circulation 2006;113:147-55.
57. Deiwick M, Hoffmeier A, Tjan T, Krasemann T, Schmid C, Scheid HH. Heart failure in children - mechanical assistance. Thorac Cardiovasc Surg 2005;53(Supp 2):S135-S140.
58. Wieselthaler GM, Schima H, Hiesmayr M, Pacher R, Laufer G, Noon GP et al. First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation. Circulation 2000;101: 356-9.
59. Tschirkov A, Nikolov D, Papantchev V. New technique for implantation of the inflow cannula of Berlin Heart INCOR system. Eur J Cardiothorac Surg 2006;30:678-9.
60. Blume ED, Naftel DC, Bastardi HJ, Duncan BW, Kirklin JK, Webber SA et al. Outcomes of children bridged to heart transplant with ventricular assist devices: a multi-institutional study. Circulation 2006;113:2313-9.
61. Fynn-Thompson F, Almond C. Pediatric ventricular assist devices. Pediatr Cardiol 2007;28:149-55.
62. excor® Pediatrics [Internet]. Berlin: Berlin Heart GmbH; C2005-2007 [cited 2007 Jan 30]. Available from: http://www.berlinheart.com/englisch/medpro/ excor-pediatric/
63. Boucek MM, Edwards LB, Keck BM Trulock EP, Taylor DO, Hertz MI. Registry for the International Society for Heart and Lung Transplantation: seventh official pediatric report 2004. J. Heart Lung Transplant 2004;23:933-47.
64. Minami K, von Knyphaseu E, Niino T, Blanz U, Blanz U, Tenderich G, Wlost S et al. Long-term result of pediatric heart transplantation. Ann Thorac Cardiovasc Surg 2005;11:386-90
65. Costanzo MR, Augustine S, Bourge R, Bristow M, O'Connell JB, Driscoll D et al. Selection and treatment of candidates for heart transplantation. Circulation 1995;92:3593-612.
66. Roussel JC, Baron O, Pèrigaud C, Bizouarn P, Pattier S, Habash O et al. Outcome of heart transplants 15 to 20 years ago: graft survival, post-transplant morbidity, and risk factors for mortality. J Heart Lung Transplant 2008;27:486-93.